25 XP   0   0   10

Tissue Regenix Group Plc
Buy, Hold or Sell?

Let's analyse Tissue Regenix Group Plc together

PenkeI guess you are interested in Tissue Regenix Group Plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tissue Regenix Group Plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tissue Regenix Group Plc

I send you an email if I find something interesting about Tissue Regenix Group Plc.

Quick analysis of Tissue Regenix Group Plc (30 sec.)










What can you expect buying and holding a share of Tissue Regenix Group Plc? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
p26.20
Expected worth in 1 year
p15.98
How sure are you?
41.7%

+ What do you gain per year?

Total Gains per Share
p-10.22
Return On Investment
-17.0%

For what price can you sell your share?

Current Price per Share
p60.20
Expected price per share
p59.00 - p70.70
How sure are you?
50%

1. Valuation of Tissue Regenix Group Plc (5 min.)




Live pricePrice per Share (EOD)

p60.20

Intrinsic Value Per Share

p-34.08 - p90.34

Total Value Per Share

p-7.88 - p116.55

2. Growth of Tissue Regenix Group Plc (5 min.)




Is Tissue Regenix Group Plc growing?

Current yearPrevious yearGrowGrow %
How rich?$23m$25.2m-$2.2m-9.8%

How much money is Tissue Regenix Group Plc making?

Current yearPrevious yearGrowGrow %
Making money-$1.3m-$2.1m$810.4k58.8%
Net Profit Margin-5.8%-11.0%--

How much money comes from the company's main activities?

3. Financial Health of Tissue Regenix Group Plc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#565 / 1010

Most Revenue
#212 / 1010

Most Profit
#264 / 1010

Most Efficient
#455 / 1010

What can you expect buying and holding a share of Tissue Regenix Group Plc? (5 min.)

Welcome investor! Tissue Regenix Group Plc's management wants to use your money to grow the business. In return you get a share of Tissue Regenix Group Plc.

What can you expect buying and holding a share of Tissue Regenix Group Plc?

First you should know what it really means to hold a share of Tissue Regenix Group Plc. And how you can make/lose money.

Speculation

The Price per Share of Tissue Regenix Group Plc is p60.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tissue Regenix Group Plc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tissue Regenix Group Plc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p26.20. Based on the TTM, the Book Value Change Per Share is p-2.56 per quarter. Based on the YOY, the Book Value Change Per Share is p0.71 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tissue Regenix Group Plc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps-0.020.0%-0.020.0%-0.04-0.1%-0.07-0.1%-0.04-0.1%
Usd Book Value Change Per Share-0.03-0.1%-0.03-0.1%0.010.0%0.060.1%0.020.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.03-0.1%-0.03-0.1%0.010.0%0.060.1%0.020.0%
Usd Price Per Share0.65-0.65-0.01-0.14-0.16-
Price to Earnings Ratio-33.16--33.16--0.18--6.72--12.93-
Price-to-Total Gains Ratio-20.35--20.35-0.80--3.90--6.92-
Price to Book Ratio1.98-1.98-0.02-0.42-4.69-
Price-to-Total Gains Ratio-20.35--20.35-0.80--3.90--6.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.7501522
Number of shares1333
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.030.06
Usd Total Gains Per Share-0.030.06
Gains per Quarter (1333 shares)-42.4579.63
Gains per Year (1333 shares)-169.81318.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-170-1800319309
20-340-3500637628
30-509-5200956947
40-679-690012741266
50-849-860015931585
60-1019-1030019111904
70-1189-1200022302223
80-1358-1370025482542
90-1528-1540028672861
100-1698-1710031853180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.012.00.00.0%0.018.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.06.01.041.7%7.010.01.038.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.012.00.0%0.00.018.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.06.01.041.7%7.010.01.038.9%

Fundamentals of Tissue Regenix Group Plc

About Tissue Regenix Group Plc

Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth. In addition, the company offers DermaPure, a decellularised dermal allograft for reinforcement, repair, and replacement of damaged or inadequate integumental tissue and other homologous uses of human integument; and SurgiPure XD, a decellularised porcine dermal reconstructive tissue matrix for the repair of hernias and body wall defects. Further, it provides OrthoPure XT, a scaffold to replace the damaged tissue that will re-populate with the patient's own cells; ConCelltrate 100, a verified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic; Matrix IQ Dermis, a human-derived dermal graft, which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Additionally, the company offers DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, a stem cell containment human scaffold; AmnioWorks to optimise membrane defects; and sports medicine products. Tissue Regenix Group plc was incorporated in 2006 and is based in Garforth, the United Kingdom.

Fundamental data was last updated by Penke on 2024-04-04 03:36:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Tissue Regenix Group Plc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tissue Regenix Group Plc earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Tissue Regenix Group Plc to the Biotechnology industry mean.
  • A Net Profit Margin of -5.8% means that -0.06 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tissue Regenix Group Plc:

  • The MRQ is -5.8%. The company is making a loss. -1
  • The TTM is -5.8%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-5.8%TTM-5.8%0.0%
TTM-5.8%YOY-11.0%+5.2%
TTM-5.8%5Y-34.1%+28.2%
5Y-34.1%10Y-8,601.8%+8,567.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.8%-200.1%+194.3%
TTM-5.8%-216.8%+211.0%
YOY-11.0%-288.3%+277.3%
5Y-34.1%-449.1%+415.0%
10Y-8,601.8%-605.5%-7,996.3%
1.1.2. Return on Assets

Shows how efficient Tissue Regenix Group Plc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tissue Regenix Group Plc to the Biotechnology industry mean.
  • -4.1% Return on Assets means that Tissue Regenix Group Plc generated -0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tissue Regenix Group Plc:

  • The MRQ is -4.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.1%TTM-4.1%0.0%
TTM-4.1%YOY-5.7%+1.7%
TTM-4.1%5Y-13.9%+9.8%
5Y-13.9%10Y-27.6%+13.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.1%-13.3%+9.2%
TTM-4.1%-12.8%+8.7%
YOY-5.7%-11.7%+6.0%
5Y-13.9%-13.9%+0.0%
10Y-27.6%-15.7%-11.9%
1.1.3. Return on Equity

Shows how efficient Tissue Regenix Group Plc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tissue Regenix Group Plc to the Biotechnology industry mean.
  • -5.8% Return on Equity means Tissue Regenix Group Plc generated -0.06 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tissue Regenix Group Plc:

  • The MRQ is -5.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.8%TTM-5.8%0.0%
TTM-5.8%YOY-8.4%+2.6%
TTM-5.8%5Y-18.0%+12.1%
5Y-18.0%10Y-31.9%+14.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.8%-16.9%+11.1%
TTM-5.8%-16.1%+10.3%
YOY-8.4%-15.1%+6.7%
5Y-18.0%-19.3%+1.3%
10Y-31.9%-20.2%-11.7%

1.2. Operating Efficiency of Tissue Regenix Group Plc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tissue Regenix Group Plc is operating .

  • Measures how much profit Tissue Regenix Group Plc makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tissue Regenix Group Plc to the Biotechnology industry mean.
  • An Operating Margin of -1.3% means the company generated -0.01  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tissue Regenix Group Plc:

  • The MRQ is -1.3%. The company is operating very inefficient. -2
  • The TTM is -1.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1.3%TTM-1.3%0.0%
TTM-1.3%YOY-8.1%+6.8%
TTM-1.3%5Y-23.5%+22.1%
5Y-23.5%10Y-9,658.3%+9,634.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.3%-296.2%+294.9%
TTM-1.3%-232.5%+231.2%
YOY-8.1%-298.2%+290.1%
5Y-23.5%-492.1%+468.6%
10Y-9,658.3%-632.4%-9,025.9%
1.2.2. Operating Ratio

Measures how efficient Tissue Regenix Group Plc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.01 means that the operating costs are 1.01 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Tissue Regenix Group Plc:

  • The MRQ is 1.013. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.013. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.013TTM1.0130.000
TTM1.013YOY1.081-0.068
TTM1.0135Y1.235-0.221
5Y1.23510Y101.607-100.372
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0133.231-2.218
TTM1.0133.310-2.297
YOY1.0813.890-2.809
5Y1.2355.739-4.504
10Y101.6077.876+93.731

1.3. Liquidity of Tissue Regenix Group Plc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tissue Regenix Group Plc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.03 means the company has 4.03 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Tissue Regenix Group Plc:

  • The MRQ is 4.032. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.032. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.032TTM4.0320.000
TTM4.032YOY3.317+0.715
TTM4.0325Y4.364-0.332
5Y4.36410Y6.768-2.404
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0323.890+0.142
TTM4.0324.173-0.141
YOY3.3175.344-2.027
5Y4.3646.126-1.762
10Y6.7686.448+0.320
1.3.2. Quick Ratio

Measures if Tissue Regenix Group Plc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tissue Regenix Group Plc to the Biotechnology industry mean.
  • A Quick Ratio of 1.84 means the company can pay off 1.84 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tissue Regenix Group Plc:

  • The MRQ is 1.844. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.844. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.844TTM1.8440.000
TTM1.844YOY1.679+0.165
TTM1.8445Y2.451-0.607
5Y2.45110Y2.488-0.037
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8443.514-1.670
TTM1.8443.998-2.154
YOY1.6795.380-3.701
5Y2.4516.105-3.654
10Y2.4886.404-3.916

1.4. Solvency of Tissue Regenix Group Plc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tissue Regenix Group Plc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tissue Regenix Group Plc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.32 means that Tissue Regenix Group Plc assets are financed with 32.1% credit (debt) and the remaining percentage (100% - 32.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tissue Regenix Group Plc:

  • The MRQ is 0.321. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.321. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.321TTM0.3210.000
TTM0.321YOY0.340-0.019
TTM0.3215Y0.275+0.046
5Y0.27510Y0.179+0.096
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3210.339-0.018
TTM0.3210.336-0.015
YOY0.3400.271+0.069
5Y0.2750.366-0.091
10Y0.1790.389-0.210
1.4.2. Debt to Equity Ratio

Measures if Tissue Regenix Group Plc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tissue Regenix Group Plc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 46.1% means that company has 0.46 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tissue Regenix Group Plc:

  • The MRQ is 0.461. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.461. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.461TTM0.4610.000
TTM0.461YOY0.500-0.040
TTM0.4615Y0.376+0.084
5Y0.37610Y0.229+0.147
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4610.388+0.073
TTM0.4610.402+0.059
YOY0.5000.335+0.165
5Y0.3760.426-0.050
10Y0.2290.461-0.232

2. Market Valuation of Tissue Regenix Group Plc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Tissue Regenix Group Plc generates.

  • Above 15 is considered overpriced but always compare Tissue Regenix Group Plc to the Biotechnology industry mean.
  • A PE ratio of -33.16 means the investor is paying -33.16 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tissue Regenix Group Plc:

  • The EOD is -38.389. Based on the earnings, the company is expensive. -2
  • The MRQ is -33.160. Based on the earnings, the company is expensive. -2
  • The TTM is -33.160. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-38.389MRQ-33.160-5.229
MRQ-33.160TTM-33.1600.000
TTM-33.160YOY-0.184-32.976
TTM-33.1605Y-6.723-26.437
5Y-6.72310Y-12.928+6.204
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-38.389-2.264-36.125
MRQ-33.160-2.629-30.531
TTM-33.160-2.680-30.480
YOY-0.184-4.145+3.961
5Y-6.723-6.257-0.466
10Y-12.928-6.254-6.674
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tissue Regenix Group Plc:

  • The EOD is -180.660. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -156.052. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -156.052. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-180.660MRQ-156.052-24.608
MRQ-156.052TTM-156.0520.000
TTM-156.052YOY-0.216-155.835
TTM-156.0525Y-31.314-124.738
5Y-31.31410Y-21.159-10.155
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-180.660-2.973-177.687
MRQ-156.052-3.333-152.719
TTM-156.052-3.553-152.499
YOY-0.216-5.605+5.389
5Y-31.314-8.376-22.938
10Y-21.159-8.865-12.294
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tissue Regenix Group Plc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.98 means the investor is paying 1.98 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Tissue Regenix Group Plc:

  • The EOD is 2.297. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.984. Based on the equity, the company is underpriced. +1
  • The TTM is 1.984. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.297MRQ1.984+0.313
MRQ1.984TTM1.9840.000
TTM1.984YOY0.020+1.965
TTM1.9845Y0.415+1.569
5Y0.41510Y4.693-4.278
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.2971.896+0.401
MRQ1.9842.115-0.131
TTM1.9842.093-0.109
YOY0.0202.884-2.864
5Y0.4153.542-3.127
10Y4.6933.916+0.777
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Tissue Regenix Group Plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.556-2.5560%0.705-463%4.794-153%1.926-233%
Book Value Per Share--26.20426.2040%28.759-9%28.539-8%13.270+97%
Current Ratio--4.0324.0320%3.317+22%4.364-8%6.768-40%
Debt To Asset Ratio--0.3210.3210%0.340-5%0.275+17%0.179+80%
Debt To Equity Ratio--0.4610.4610%0.500-8%0.376+22%0.229+101%
Dividend Per Share----0%-0%-0%-0%
Eps---1.568-1.5680%-3.067+96%-5.814+271%-2.915+86%
Free Cash Flow Per Share---0.333-0.3330%-2.611+683%-4.794+1339%-2.643+693%
Free Cash Flow To Equity Per Share---1.198-1.1980%-1.354+13%-0.973-19%-0.116-90%
Gross Profit Margin---1.048-1.0480%-0.150-86%0.175-698%0.656-260%
Intrinsic Value_10Y_max--90.341--------
Intrinsic Value_10Y_min---34.079--------
Intrinsic Value_1Y_max--0.012--------
Intrinsic Value_1Y_min---4.492--------
Intrinsic Value_3Y_max--6.925--------
Intrinsic Value_3Y_min---12.644--------
Intrinsic Value_5Y_max--22.146--------
Intrinsic Value_5Y_min---19.799--------
Market Cap4248584659.200+14%3669873792.0003669873792.0000%39874590.240+9104%771209862.490+376%6826914210.525-46%
Net Profit Margin---0.058-0.0580%-0.110+90%-0.341+486%-86.018+148000%
Operating Margin---0.013-0.0130%-0.081+507%-0.235+1658%-96.583+722885%
Operating Ratio--1.0131.0130%1.081-6%1.235-18%101.607-99%
Pb Ratio2.297+14%1.9841.9840%0.020+10001%0.415+378%4.693-58%
Pe Ratio-38.389-16%-33.160-33.1600%-0.184-99%-6.723-80%-12.928-61%
Price Per Share60.200+14%52.00052.0000%0.565+9104%10.928+376%13.149+295%
Price To Free Cash Flow Ratio-180.660-16%-156.052-156.0520%-0.216-100%-31.314-80%-21.159-86%
Price To Total Gains Ratio-23.555-16%-20.346-20.3460%0.801-2639%-3.901-81%-6.922-66%
Quick Ratio--1.8441.8440%1.679+10%2.451-25%2.488-26%
Return On Assets---0.041-0.0410%-0.057+41%-0.139+241%-0.276+580%
Return On Equity---0.058-0.0580%-0.084+45%-0.180+208%-0.319+448%
Total Gains Per Share---2.556-2.5560%0.705-463%4.794-153%1.926-233%
Usd Book Value--23044249.09423044249.0940%25291865.631-9%25097787.956-8%25064421.953-8%
Usd Book Value Change Per Share---0.032-0.0320%0.009-463%0.060-153%0.024-233%
Usd Book Value Per Share--0.3270.3270%0.358-9%0.356-8%0.165+97%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.020-0.0200%-0.038+96%-0.072+271%-0.036+86%
Usd Free Cash Flow---293045.545-293045.5450%-2295944.414+683%-4216278.590+1339%-6031372.691+1958%
Usd Free Cash Flow Per Share---0.004-0.0040%-0.033+683%-0.060+1339%-0.033+693%
Usd Free Cash Flow To Equity Per Share---0.015-0.0150%-0.017+13%-0.012-19%-0.001-90%
Usd Market Cap52941613.438+14%45730297.32245730297.3220%496877.269+9104%9610046.096+376%85070177.977-46%
Usd Price Per Share0.750+14%0.6480.6480%0.007+9104%0.136+376%0.164+295%
Usd Profit---1379082.774-1379082.7740%-2189515.405+59%-4749979.988+244%-6899310.845+400%
Usd Revenue--23743909.49323743909.4930%19885189.940+19%16775706.588+42%9028891.424+163%
Usd Total Gains Per Share---0.032-0.0320%0.009-463%0.060-153%0.024-233%
 EOD+5 -3MRQTTM+0 -0YOY+23 -115Y+17 -1710Y+18 -16

3.2. Fundamental Score

Let's check the fundamental score of Tissue Regenix Group Plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-38.389
Price to Book Ratio (EOD)Between0-12.297
Net Profit Margin (MRQ)Greater than0-0.058
Operating Margin (MRQ)Greater than0-0.013
Quick Ratio (MRQ)Greater than11.844
Current Ratio (MRQ)Greater than14.032
Debt to Asset Ratio (MRQ)Less than10.321
Debt to Equity Ratio (MRQ)Less than10.461
Return on Equity (MRQ)Greater than0.15-0.058
Return on Assets (MRQ)Greater than0.05-0.041
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Tissue Regenix Group Plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.615
Ma 20Greater thanMa 5061.500
Ma 50Greater thanMa 10064.542
Ma 100Greater thanMa 20060.031
OpenGreater thanClose61.480
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
EBITDA  -492,541223,101-269,44093,615-175,825120,341-55,48493,15037,666



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets33,921
Total Liabilities10,894
Total Stockholder Equity23,651
 As reported
Total Liabilities 10,894
Total Stockholder Equity+ 23,651
Total Assets = 33,921

Assets

Total Assets33,921
Total Current Assets14,975
Long-term Assets18,947
Total Current Assets
Cash And Cash Equivalents 3,648
Net Receivables 3,202
Inventory 8,125
Other Current Assets 0
Total Current Assets  (as reported)14,975
Total Current Assets  (calculated)14,975
+/-0
Long-term Assets
Property Plant Equipment 7,074
Goodwill 11,587
Intangible Assets 3,548
Long-term Assets Other -3,263
Long-term Assets  (as reported)18,947
Long-term Assets  (calculated)18,947
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,714
Long-term Liabilities7,180
Total Stockholder Equity23,651
Total Current Liabilities
Short-term Debt 504
Short Long Term Debt 458
Accounts payable 2,968
Other Current Liabilities 243
Total Current Liabilities  (as reported)3,714
Total Current Liabilities  (calculated)4,172
+/- 458
Long-term Liabilities
Long term Debt 5,527
Capital Lease Obligations Min Short Term Debt2,906
Long-term Liabilities  (as reported)7,180
Long-term Liabilities  (calculated)8,433
+/- 1,253
Total Stockholder Equity
Common Stock12,512
Retained Earnings -92,658
Accumulated Other Comprehensive Income -529
Other Stockholders Equity 104,327
Total Stockholder Equity (as reported)23,651
Total Stockholder Equity (calculated)23,651
+/-0
Other
Capital Stock91
Cash and Short Term Investments 3,648
Common Stock Shares Outstanding 70,427
Liabilities and Stockholders Equity 33,921
Net Debt 3,722
Net Invested Capital 36,135
Net Working Capital 14,355
Property Plant and Equipment Gross 14,429
Short Long Term Debt Total 7,370



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312018-01-312017-12-312016-12-312016-01-312015-01-312014-01-312013-01-312012-01-312011-01-312010-01-312009-01-312008-01-312007-07-312007-01-31
> Total Assets 
2,932
0
4,912
2,564
2,327
6,471
28,528
25,151
20,082
12,673
23,197
13,601
45,762
45,762
37,663
30,495
36,731
34,127
38,273
33,921
33,92138,27334,12736,73130,49537,66345,76245,76213,60123,19712,67320,08225,15128,5286,4712,3272,5644,91202,932
   > Total Current Assets 
0
0
2,790
2,562
2,327
6,282
28,371
24,913
19,610
12,238
22,296
11,964
23,463
23,463
14,897
10,139
20,090
16,289
18,318
14,975
14,97518,31816,28920,09010,13914,89723,46323,46311,96422,29612,23819,61024,91328,3716,2822,3272,5622,79000
       Cash And Cash Equivalents 
0
0
2,761
2,534
2,316
5,889
28,021
24,206
18,483
10,257
19,907
8,173
16,423
16,423
7,816
2,380
9,550
5,692
4,946
3,648
3,6484,9465,6929,5502,3807,81616,42316,4238,17319,90710,25718,48324,20628,0215,8892,3162,5342,76100
       Net Receivables 
0
0
6
6
2
351
299
656
807
1,455
1,862
427
3,660
0
4,195
3,574
3,468
3,422
4,326
3,202
3,2024,3263,4223,4683,5744,19503,6604271,8621,45580765629935126600
       Other Current Assets 
0
0
23
22
9
42
51
51
320
492
463
472
4,168
4,168
4,751
0
1,258
1,213
5,204
0
05,2041,2131,25804,7514,1684,1684724634923205151429222300
   > Long-term Assets 
0
0
2,122
2
0
189
157
238
472
435
901
0
22,299
22,299
22,766
20,356
16,641
17,837
19,955
18,947
18,94719,95517,83716,64120,35622,76622,29922,2990901435472238157189022,12200
       Property Plant Equipment 
0
0
2
2
0
189
157
238
472
435
901
1,087
2,994
2,994
2,828
2,357
5,710
6,716
7,435
7,074
7,0747,4356,7165,7102,3572,8282,9942,9941,08790143547223815718902200
       Goodwill 
0
0
2,120
0
0
0
0
0
0
0
0
0
14,504
14,504
15,333
15,262
8,610
8,555
9,633
11,587
11,5879,6338,5558,61015,26215,33314,50414,5040000000002,12000
       Intangible Assets 
0
0
2,120
0
0
0
0
0
0
0
0
550
4,801
4,801
4,605
17,999
10,931
11,122
12,521
3,548
3,54812,52111,12210,93117,9994,6054,8014,801550000000002,12000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
550
643
0
759
0
0
0
0
0
00000759064355000000000000
> Total Liabilities 
8
0
42
42
32
253
649
685
1,104
1,095
1,958
1,856
6,240
6,240
5,093
5,900
8,884
9,473
13,000
10,894
10,89413,0009,4738,8845,9005,0936,2406,2401,8561,9581,0951,10468564925332424208
   > Total Current Liabilities 
0
0
42
42
32
253
649
685
1,104
1,095
1,958
2,065
4,781
4,781
4,302
3,115
3,263
3,220
5,523
3,714
3,7145,5233,2203,2633,1154,3024,7814,7812,0651,9581,0951,10468564925332424200
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
171
256
87
943
504
50494387256171000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
171
0
0
1,000
458
4581,00000171000000000000000
       Accounts payable 
0
0
17
12
4
168
287
205
368
312
501
618
1,519
1,519
855
1,650
975
1,900
2,858
2,968
2,9682,8581,9009751,6508551,5191,5196185013123682052871684121700
       Other Current Liabilities 
0
0
25
30
28
85
362
480
736
73
72
147
3,262
3,262
3,371
1,294
2,032
1,233
1,723
243
2431,7231,2332,0321,2943,3713,2623,26214772737364803628528302500
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
1,459
1,459
791
2,785
5,621
6,253
7,477
7,180
7,1807,4776,2535,6212,7857911,4591,459000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
1,459
0
791
670
560
640
520
0
052064056067079101,459000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
550
643
0
759
0
215
788
1,403
0
01,4037882150759064355000000000000
> Total Stockholder Equity
0
0
4,870
2,522
2,295
6,218
27,879
24,466
18,978
11,578
21,322
11,745
39,931
39,931
33,052
25,210
28,461
25,355
25,981
23,651
23,65125,98125,35528,46125,21033,05239,93139,93111,74521,32211,57818,97824,46627,8796,2182,2952,5224,87000
   Common Stock
0
0
600
600
600
2,343
3,262
3,264
3,267
3,271
3,801
3,801
5,855
5,855
5,859
5,859
11,720
11,774
13,260
12,512
12,51213,26011,77411,7205,8595,8595,8555,8553,8013,8013,2713,2673,2643,2622,34360060060000
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 
0
0
-1
-2
0
-82
-144
-218
-342
-493
-738
0
-1,521
0
-2,169
983
955
198
-943
-529
-529-943198955983-2,1690-1,5210-738-493-342-218-144-820-2-100
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
50,461
86,398
0
86,398
86,399
94,290
0
0
0
00094,29086,39986,398086,39850,46100000000000
   Treasury Stock0000000-831-831-831-831-831-831-831-82800000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
4,366
4,546
4,682
4,892
92,010
0
92,601
85,568
93,459
98,133
110,501
104,327
104,327110,50198,13393,45985,56892,601092,0104,8924,6824,5464,36600000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue23,726
Cost of Revenue-12,432
Gross Profit11,29511,295
 
Operating Income (+$)
Gross Profit11,295
Operating Expense-11,612
Operating Income-317-317
 
Operating Expense (+$)
Research Development-
Selling General Administrative14,434
Selling And Marketing Expenses-2,822
Operating Expense11,61211,612
 
Net Interest Income (+$)
Interest Income26
Interest Expense-1,047
Other Finance Cost-254
Net Interest Income-1,275
 
Pretax Income (+$)
Operating Income-317
Net Interest Income-1,275
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,343709
EBIT - interestExpense = -1,364
-1,388
-331
Interest Expense1,047
Earnings Before Interest and Taxes (EBIT)-317-296
Earnings Before Interest and Taxes (EBITDA)469
 
After tax Income (+$)
Income Before Tax-1,343
Tax Provision--12
Net Income From Continuing Ops-1,657-1,331
Net Income-1,378
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses24,043
Total Other Income/Expenses Net-1,0261,275
 

Technical Analysis of Tissue Regenix Group Plc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tissue Regenix Group Plc. The general trend of Tissue Regenix Group Plc is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tissue Regenix Group Plc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tissue Regenix Group Plc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 63.20 < 66.60 < 70.70.

The bearish price targets are: 59.80 > 59.80 > 59.00.

Tweet this
Tissue Regenix Group Plc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tissue Regenix Group Plc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tissue Regenix Group Plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tissue Regenix Group Plc. The current macd is -0.88090015.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tissue Regenix Group Plc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tissue Regenix Group Plc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tissue Regenix Group Plc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Tissue Regenix Group Plc Daily Moving Average Convergence/Divergence (MACD) ChartTissue Regenix Group Plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tissue Regenix Group Plc. The current adx is 40.53.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tissue Regenix Group Plc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Tissue Regenix Group Plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tissue Regenix Group Plc. The current sar is 62.48.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tissue Regenix Group Plc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tissue Regenix Group Plc. The current rsi is 36.61. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Tissue Regenix Group Plc Daily Relative Strength Index (RSI) ChartTissue Regenix Group Plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tissue Regenix Group Plc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tissue Regenix Group Plc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Tissue Regenix Group Plc Daily Stochastic Oscillator ChartTissue Regenix Group Plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tissue Regenix Group Plc. The current cci is -144.79705236.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Tissue Regenix Group Plc Daily Commodity Channel Index (CCI) ChartTissue Regenix Group Plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tissue Regenix Group Plc. The current cmo is -34.85453086.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tissue Regenix Group Plc Daily Chande Momentum Oscillator (CMO) ChartTissue Regenix Group Plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tissue Regenix Group Plc. The current willr is -88.23529412.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Tissue Regenix Group Plc Daily Williams %R ChartTissue Regenix Group Plc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tissue Regenix Group Plc.

Tissue Regenix Group Plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tissue Regenix Group Plc. The current atr is 1.61308255.

Tissue Regenix Group Plc Daily Average True Range (ATR) ChartTissue Regenix Group Plc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tissue Regenix Group Plc. The current obv is 1,736,374,336.

Tissue Regenix Group Plc Daily On-Balance Volume (OBV) ChartTissue Regenix Group Plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tissue Regenix Group Plc. The current mfi is 49.54.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Tissue Regenix Group Plc Daily Money Flow Index (MFI) ChartTissue Regenix Group Plc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tissue Regenix Group Plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Tissue Regenix Group Plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tissue Regenix Group Plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.615
Ma 20Greater thanMa 5061.500
Ma 50Greater thanMa 10064.542
Ma 100Greater thanMa 20060.031
OpenGreater thanClose61.480
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tissue Regenix Group Plc with someone you think should read this too:
  • Are you bullish or bearish on Tissue Regenix Group Plc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tissue Regenix Group Plc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tissue Regenix Group Plc

I send you an email if I find something interesting about Tissue Regenix Group Plc.


Comments

How you think about this?

Leave a comment

Stay informed about Tissue Regenix Group Plc.

Receive notifications about Tissue Regenix Group Plc in your mailbox!